• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    More On ENMD

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    (ENMD)

    -NasdaqCM
    0.00 0.00(0.00%) N/A
    Add to Portfolio
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:2.31
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:1.45 - 2.34
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in .

    Headlines

    • No Headlines available for ENMD at this time.

    Comparison

    Symbol% ChgMkt Cap
    ENMD 0.00%N/A
    PGLADown 12.79%8.29M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    EntreMed, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback